 | • レポートコード：MRC23Q37932 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のモノアミンオキシダーゼ-B市場について調査・分析し、世界のモノアミンオキシダーゼ-B市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（非選択的MAO-B阻害剤、選択的MAO-B阻害剤）、用途別セグメント分析（非定型うつ病治療、パーキンソン病治療、その他治療）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Novartis、Pfizer、Validus Pharmaceuticals LLC、Eli Lilly & Company、GlaxoSmithKline、Merck & Co、Concordia Pharmsなどが含まれています。世界のモノアミンオキシダーゼ-B市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、モノアミンオキシダーゼ-B市場規模を推定する際に考慮しました。本レポートは、モノアミンオキシダーゼ-Bの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、モノアミンオキシダーゼ-Bに関するビジネス上の意思決定に役立てることを目的としています。 ・モノアミンオキシダーゼ-B市場の概要 - 製品の定義 - モノアミンオキシダーゼ-Bのタイプ別セグメント - 世界のモノアミンオキシダーゼ-B市場規模：タイプ別分析（非選択的MAO-B阻害剤、選択的MAO-B阻害剤） - モノアミンオキシダーゼ-Bの用途別セグメント - 世界のモノアミンオキシダーゼ-B市場規模：用途別分析（非定型うつ病治療、パーキンソン病治療、その他治療） - 世界のモノアミンオキシダーゼ-B市場規模予測（2018年-2029年） - モノアミンオキシダーゼ-Bの平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - モノアミンオキシダーゼ-B市場の競争状況およびトレンド ・モノアミンオキシダーゼ-Bの地域別市場規模 - 北米のモノアミンオキシダーゼ-B市場規模（2018年-2029年） - アメリカのモノアミンオキシダーゼ-B市場規模（2018年-2029年） - ヨーロッパのモノアミンオキシダーゼ-B市場規模（2018年-2029年） - アジア太平洋のモノアミンオキシダーゼ-B市場規模（2018年-2029年） - 中国のモノアミンオキシダーゼ-B市場規模（2018年-2029年） - 日本のモノアミンオキシダーゼ-B市場規模（2018年-2029年） - 韓国のモノアミンオキシダーゼ-B市場規模（2018年-2029年） - インドのモノアミンオキシダーゼ-B市場規模（2018年-2029年） - オーストラリアのモノアミンオキシダーゼ-B市場規模（2018年-2029年） - 中南米のモノアミンオキシダーゼ-B市場規模（2018年-2029年） - 中東・アフリカのモノアミンオキシダーゼ-B市場規模（2018年-2029年） ・タイプ別セグメント：非選択的MAO-B阻害剤、選択的MAO-B阻害剤 - 世界のモノアミンオキシダーゼ-Bのタイプ別販売量（2018年-2023年） - 世界のモノアミンオキシダーゼ-Bのタイプ別売上（2018年-2023年） - 世界のモノアミンオキシダーゼ-Bのタイプ別価格 ・用途別セグメント：非定型うつ病治療、パーキンソン病治療、その他治療 - 世界のモノアミンオキシダーゼ-Bの用途別販売量（2018年-2023年） - 世界のモノアミンオキシダーゼ-Bの用途別売上（2018年-2023年） - 世界のモノアミンオキシダーゼ-Bの用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Novartis、Pfizer、Validus Pharmaceuticals LLC、Eli Lilly & Company、GlaxoSmithKline、Merck & Co、Concordia Pharms ・産業チェーンと販売チャネルの分析 - モノアミンオキシダーゼ-B産業チェーン分析 - モノアミンオキシダーゼ-Bの主要原材料 - モノアミンオキシダーゼ-Bの販売チャネル - モノアミンオキシダーゼ-Bのディストリビューター - モノアミンオキシダーゼ-Bの主要顧客 ・モノアミンオキシダーゼ-B市場ダイナミクス - モノアミンオキシダーゼ-Bの業界動向 - モノアミンオキシダーゼ-B市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Monoamine Oxidase-B market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Monoamine Oxidase-B is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Monoamine Oxidase-B is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Monoamine Oxidase-B include Novartis, Pfizer, Validus Pharmaceuticals LLC, Eli Lilly & Company, GlaxoSmithKline, Merck & Co and Concordia Pharms, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Monoamine Oxidase-B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Monoamine Oxidase-B.
The Monoamine Oxidase-B market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Monoamine Oxidase-B market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Monoamine Oxidase-B manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Novartis
Pfizer
Validus Pharmaceuticals LLC
Eli Lilly & Company
GlaxoSmithKline
Merck & Co
Concordia Pharms
Segment by Type
Nonselective MAO-B inhibitors
Selective MAO-B inhibitors
Segment by Application
Atypical Depression Treatment
Parkinson’s Disease Treatment
Other Therapy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Monoamine Oxidase-B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Monoamine Oxidase-B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Monoamine Oxidase-B Market Overview
1.1 Product Overview and Scope of Monoamine Oxidase-B
1.2 Monoamine Oxidase-B Segment by Type
1.2.1 Global Monoamine Oxidase-B Market Value Comparison by Type (2023-2029)
1.2.2 Nonselective MAO-B inhibitors
1.2.3 Selective MAO-B inhibitors
1.3 Monoamine Oxidase-B Segment by Application
1.3.1 Global Monoamine Oxidase-B Market Value by Application: (2023-2029)
1.3.2 Atypical Depression Treatment
1.3.3 Parkinson’s Disease Treatment
1.3.4 Other Therapy
1.4 Global Monoamine Oxidase-B Market Size Estimates and Forecasts
1.4.1 Global Monoamine Oxidase-B Revenue 2018-2029
1.4.2 Global Monoamine Oxidase-B Sales 2018-2029
1.4.3 Global Monoamine Oxidase-B Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Monoamine Oxidase-B Market Competition by Manufacturers
2.1 Global Monoamine Oxidase-B Sales Market Share by Manufacturers (2018-2023)
2.2 Global Monoamine Oxidase-B Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Monoamine Oxidase-B Average Price by Manufacturers (2018-2023)
2.4 Global Monoamine Oxidase-B Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Monoamine Oxidase-B, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Monoamine Oxidase-B, Product Type & Application
2.7 Monoamine Oxidase-B Market Competitive Situation and Trends
2.7.1 Monoamine Oxidase-B Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Monoamine Oxidase-B Players Market Share by Revenue
2.7.3 Global Monoamine Oxidase-B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Monoamine Oxidase-B Retrospective Market Scenario by Region
3.1 Global Monoamine Oxidase-B Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Monoamine Oxidase-B Global Monoamine Oxidase-B Sales by Region: 2018-2029
3.2.1 Global Monoamine Oxidase-B Sales by Region: 2018-2023
3.2.2 Global Monoamine Oxidase-B Sales by Region: 2024-2029
3.3 Global Monoamine Oxidase-B Global Monoamine Oxidase-B Revenue by Region: 2018-2029
3.3.1 Global Monoamine Oxidase-B Revenue by Region: 2018-2023
3.3.2 Global Monoamine Oxidase-B Revenue by Region: 2024-2029
3.4 North America Monoamine Oxidase-B Market Facts & Figures by Country
3.4.1 North America Monoamine Oxidase-B Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Monoamine Oxidase-B Sales by Country (2018-2029)
3.4.3 North America Monoamine Oxidase-B Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Monoamine Oxidase-B Market Facts & Figures by Country
3.5.1 Europe Monoamine Oxidase-B Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Monoamine Oxidase-B Sales by Country (2018-2029)
3.5.3 Europe Monoamine Oxidase-B Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Monoamine Oxidase-B Market Facts & Figures by Country
3.6.1 Asia Pacific Monoamine Oxidase-B Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Monoamine Oxidase-B Sales by Country (2018-2029)
3.6.3 Asia Pacific Monoamine Oxidase-B Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Monoamine Oxidase-B Market Facts & Figures by Country
3.7.1 Latin America Monoamine Oxidase-B Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Monoamine Oxidase-B Sales by Country (2018-2029)
3.7.3 Latin America Monoamine Oxidase-B Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Monoamine Oxidase-B Market Facts & Figures by Country
3.8.1 Middle East and Africa Monoamine Oxidase-B Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Monoamine Oxidase-B Sales by Country (2018-2029)
3.8.3 Middle East and Africa Monoamine Oxidase-B Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Monoamine Oxidase-B Sales by Type (2018-2029)
4.1.1 Global Monoamine Oxidase-B Sales by Type (2018-2023)
4.1.2 Global Monoamine Oxidase-B Sales by Type (2024-2029)
4.1.3 Global Monoamine Oxidase-B Sales Market Share by Type (2018-2029)
4.2 Global Monoamine Oxidase-B Revenue by Type (2018-2029)
4.2.1 Global Monoamine Oxidase-B Revenue by Type (2018-2023)
4.2.2 Global Monoamine Oxidase-B Revenue by Type (2024-2029)
4.2.3 Global Monoamine Oxidase-B Revenue Market Share by Type (2018-2029)
4.3 Global Monoamine Oxidase-B Price by Type (2018-2029)
5 Segment by Application
5.1 Global Monoamine Oxidase-B Sales by Application (2018-2029)
5.1.1 Global Monoamine Oxidase-B Sales by Application (2018-2023)
5.1.2 Global Monoamine Oxidase-B Sales by Application (2024-2029)
5.1.3 Global Monoamine Oxidase-B Sales Market Share by Application (2018-2029)
5.2 Global Monoamine Oxidase-B Revenue by Application (2018-2029)
5.2.1 Global Monoamine Oxidase-B Revenue by Application (2018-2023)
5.2.2 Global Monoamine Oxidase-B Revenue by Application (2024-2029)
5.2.3 Global Monoamine Oxidase-B Revenue Market Share by Application (2018-2029)
5.3 Global Monoamine Oxidase-B Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novartis Monoamine Oxidase-B Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Monoamine Oxidase-B Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Validus Pharmaceuticals LLC
6.3.1 Validus Pharmaceuticals LLC Corporation Information
6.3.2 Validus Pharmaceuticals LLC Description and Business Overview
6.3.3 Validus Pharmaceuticals LLC Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Validus Pharmaceuticals LLC Monoamine Oxidase-B Product Portfolio
6.3.5 Validus Pharmaceuticals LLC Recent Developments/Updates
6.4 Eli Lilly & Company
6.4.1 Eli Lilly & Company Corporation Information
6.4.2 Eli Lilly & Company Description and Business Overview
6.4.3 Eli Lilly & Company Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Eli Lilly & Company Monoamine Oxidase-B Product Portfolio
6.4.5 Eli Lilly & Company Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.5.4 GlaxoSmithKline Monoamine Oxidase-B Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Merck & Co
6.6.1 Merck & Co Corporation Information
6.6.2 Merck & Co Description and Business Overview
6.6.3 Merck & Co Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Merck & Co Monoamine Oxidase-B Product Portfolio
6.6.5 Merck & Co Recent Developments/Updates
6.7 Concordia Pharms
6.6.1 Concordia Pharms Corporation Information
6.6.2 Concordia Pharms Description and Business Overview
6.6.3 Concordia Pharms Monoamine Oxidase-B Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Concordia Pharms Monoamine Oxidase-B Product Portfolio
6.7.5 Concordia Pharms Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Monoamine Oxidase-B Industry Chain Analysis
7.2 Monoamine Oxidase-B Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Monoamine Oxidase-B Production Mode & Process
7.4 Monoamine Oxidase-B Sales and Marketing
7.4.1 Monoamine Oxidase-B Sales Channels
7.4.2 Monoamine Oxidase-B Distributors
7.5 Monoamine Oxidase-B Customers
8 Monoamine Oxidase-B Market Dynamics
8.1 Monoamine Oxidase-B Industry Trends
8.2 Monoamine Oxidase-B Market Drivers
8.3 Monoamine Oxidase-B Market Challenges
8.4 Monoamine Oxidase-B Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer